Valuation: RAMM Pharma Corp.

Market Cap 6L 4L 4L 3L 3L 4.1Cr 6L 40.99L 16.1L 2Cr 15.97L 15.62L 6.91Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value -1L -90.14T -78.79T -72.86T -66.86T -86.85L -1L -9L -3L -42.41L -3L -3L -1.46Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 week-50.00%
Current month-50.00%
1 month-66.67%
3 months-66.67%
6 months-87.50%
Current year-91.67%
1 week 0
Extreme 0.005
0
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.8
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/06/25 Sell

Chief Executive Officer

46,67,000 3.9091%
21/03/25 Buy

Chief Executive Officer

1,00,000 0.0838%
21/03/25 Buy

Chief Executive Officer

2,00,000 0.1675%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-50.00%-50.00%-91.67% 4L
+1.08%-3.84%+51.50%+160.13% 1,03100Cr
+1.19%-5.10%+61.09%+56.36% 59TCr
+4.21%+0.65%+36.48%+87.04% 43TCr
+0.42%-0.99%+30.04%+22.27% 33TCr
+1.03%-2.10%+28.32%+45.08% 28TCr
+0.49%-11.32%+20.31%+22.32% 26TCr
+1.59%+3.91%-22.47%-36.84% 22TCr
+3.70%+0.98%+27.03%+63.38% 19TCr
+3.49%+0.35%+24.98%+76.58% 16TCr
Average +1.47%-3.41%+20.73%+40.46% 35.04TCr
Weighted average by Cap. +1.55%-4.31%+37.79%+79.43%

Financials

2024 2025
Net sales 43.42L 30.93L 27.03L 25L 22.94L 30Cr 44.17L 2.98Cr 1.17Cr 15Cr 1.16Cr 1.14Cr 50Cr 33.61L 23.94L 20.92L 19.35L 17.76L 23Cr 34.19L 2.31Cr 90.65L 11Cr 89.9L 87.92L 39Cr
Net income -1.65Cr -1.18Cr -1.03Cr -95.02L -87.19L -113.26Cr -1.68Cr -11Cr -4.45Cr -55Cr -4.41Cr -4.32Cr -190.96Cr -89.1L -63.47L -55.48L -51.3L -47.08L -61Cr -90.65L -6.12Cr -2.4Cr -30Cr -2.38Cr -2.33Cr -103.1Cr
Net Debt -6L -4L -4L -4L -3L -4.29Cr -6L -42.97L -16.88L -2.1Cr -16.74L -16.37L -7.24Cr -7L -5L -5L -4L -4L -4.97Cr -7L -49.68L -19.52L -2.42Cr -19.35L -18.93L -8.37Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock